Analysis of activation-induced cytidine deaminase mRNA levels in patients with chronic lymphocytic leukemia with different cytogenetic status

References

• Matutes E, Attygalle A, Wotherspoon A, et al. Diagnostic issues in chronic lymphocytic leukaemia (CLL). Best Pract Res Clin Haematol 2010;23:3–20.
   PubMed Web of Science ®Google Scholar
• Dighiero G, Hamblin TJ. Chronic lymphocytic leukaemia. Lancet 2008;371:1017–1029.
   PubMed Web of Science ®Google Scholar
• Damle RN, Calissano C, Chiorazzi N. Chronic lymphocytic leukaemia: a disease of activated monoclonal B cells. Best Pract Res Clin Haematol 2010;23:33–45.
   PubMed Web of Science ®Google Scholar
• Nordgren TM, Joshi SS. The etiology of chronic lymphocytic leukemia: another look at the relationship between B1 cells and CLL. Open Leuk J 2010;3:69–73.
   Google Scholar
• Shanafelt TD. Predicting clinical outcome in CLL: how and why. Hematology Am Soc Hematol Educ Program 2009:421–429.
   PubMedGoogle Scholar
• Swanepoel DC, Houlston RS. Genetic variation and risk of chronic lymphocytic leukaemia. Semin Cancer Biol 2010;20:363–369.
   PubMed Web of Science ®Google Scholar
• Hallek M, Cheson BD, Catovsky D, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia (IWCLL) updating the National Cancer Institute-Working Group (NCI-WG) 1996 guidelines. Blood 2008;111:5446–5456.
   PubMed Web of Science ®Google Scholar
• Hasserjian RP. Chronic lymphocytic leukemia, small lymphocytic lymphoma, and monoclonal B-cell lymphocytosis. Surg Pathol 2010;3:907–931.
   Google Scholar
• Dicker F, Schnittger S, Haferlach T, et al. Immunostimulatory oligonucleotide-induced metaphase cytogenetics detects chromosomal aberrations in 80% of CLL patients: a study of 132 CLL cases with correlation to FISH, IgVH status, and CD38 expression. Blood 2006;108:3151–3160.
   Google Scholar
• Rawstron AC. Monoclonal B-cell lymphocytosis. Hematology Am Soc Hematol Educ Program 2009:430–439.
   Google Scholar
• Kipps TJ. The B-cell receptor and ZAP-70 in chronic lymphocytic leukemia. Best Pract Res Clin Haemetol 2007;20:415–424
   PubMed Web of Science ®Google Scholar
• Leuenberger M, Frigerio S, Wild PJ, et al. AID protein expression in chronic lymphocytic leukemia/small lymphocytic lymphoma is associated with poor prognosis and complex genetic alterations. Mod Pathol 2010;23:177–186.
   PubMed Web of Science ®Google Scholar
• Iacobucci I, Lonetti A, Messa F, et al. Different isoforms of the B-cell mutator activation-induced cytidine deaminase are aberrantly expressed in BCR–ABL1-positive acute lymphoblastic leukemia patients. Leukemia 2010;24:66–73.
   PubMed Web of Science ®Google Scholar
• Muramatsu M, Sankaranand VS, Anant S, et al. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J Biol Chem 1999;274:18470–18476.
   PubMed Web of Science ®Google Scholar
• Noguchi E, Shibasaki M, Inudou M, et al. Association between a new polymorphism in the activation-induced cytidine deaminase gene and atopic asthma and the regulation of total serum IgE levels. J Allergy Clin Immunol 2001;108:382–386.
   PubMed Web of Science ®Google Scholar
• McCarthy H, Wierda WG, Baron LL, et al. High expression of activation-induced cytidine deaminase (AID) and splice variants is a distinctive feature of poor-prognosis chronic lymphocytic leukemia. Blood 2003;101:903–4908.
   PubMed Web of Science ®Google Scholar
• Boursier L, Wen Su, Spencer J. Analysis of strand biased “G”.C hypermutation in human immunoglobulin V(lambda) gene segments suggests that both DNA strands are targets for deamination by activation-induced cytidine deaminase. Mol Immunol 2004;40: 1273–1278.
   PubMed Web of Science ®Google Scholar
• Yebenes VG, Ramiro AR. Activation-induced deaminase: light and dark sides. Trends Mol Med 2006;12:432–439.
   PubMed Web of Science ®Google Scholar
• Marusawa H, Chiba T. Helicobacter pylori-induced activation-induced cytidine deaminase expression and carcinogenesis. Curr Opin Immunol 2010;22:442–447.
   PubMed Web of Science ®Google Scholar
• Nakamura M, Sugita K, Sawada Y, et al. High levels of activation-induced cytidine deaminase expression in adult T-cell leukemia lymphoma. Br J Dermatol 2011;458:717–724.
   Google Scholar
• Qin H, Suzuki K, Nakata M, et al. Activation-induced cytidine deaminase expression in CD4 + T cells is associated with a unique IL-10-producing subset that increases with age. PLoS One 2011;6:e29141.
   PubMed Web of Science ®Google Scholar
• Palacios F, Moreno P, Morande P, et al. High expression of AID and active class switch recombination might account for a more aggressive disease in unmutated CLL patients: link with an activated microenvironment in CLL disease. Blood 2010;115:4488–4496.
   PubMed Web of Science ®Google Scholar
• Fujimura S, Matsui T, Kuwahara K, et al. Germinal center B-cell-associated DNA hypomethylation at transcriptional regions of the AID gene. Mol Immunol 2008;45:1712–1719.
   PubMed Web of Science ®Google Scholar
• Basu U, Franklin A, Schwer B, et al. Regulation of activation-induced cytidine deaminase DNA deamination activity in B-cells by Ser38 phosphorylation. Biochem Soc Trans 2009;37:561–568.
   PubMed Web of Science ®Google Scholar
• Liu M, Schatz DG. Balancing AID and DNA repair during somatic hypermutation. Trends Immunol 2009;30:173–181.
   PubMed Web of Science ®Google Scholar
• Yamane A, Resch W, Kuo N, et al. Deep-sequencing identification of the genomic targets of the cytidine deaminase AID and its cofactor RPA in B lymphocytes. Nat Immunol 2011;12:62–70.
   PubMed Web of Science ®Google Scholar
• Ramiro AR, Jankovic M, Eisenreich T, et al. AID is required for c-myc/IgH chromosome translocations in vivo. Cell 2004;118: 431–438.
   PubMed Web of Science ®Google Scholar
• Robbiani DF, Bothmer A, Callen E, et al. AID is required for the chromosomal breaks in c-myc that lead to c-myc/IgH translocations. Cell 2008;135:1028–1038.
   PubMed Web of Science ®Google Scholar
• Hancer VS, Kose M, Diz-Kucukkaya R, et al. Activation-induced cytidine deaminase mRNA levels in chronic lymphocytic leukemia. Leuk Lymphoma 2011;52:79–84.
   PubMed Web of Science ®Google Scholar
• Cheson BD, Bennett JM, Grever M, et al. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 1996;87:4990–4997.
   PubMed Web of Science ®Google Scholar
• Matutes E, Owusu-Ankomah K, Morilla R, et al. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 1994;8:1640–1645.
   PubMed Web of Science ®Google Scholar
• Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008;3:1101–1108.
   PubMed Web of Science ®Google Scholar
• Maul RW, Saribasak H, Martomo SA, et al. Uracil residues dependent on the deaminase AID in immunoglobulin gene variable and switch regions. Nat Immunol 2011;12:70–77.
   PubMed Web of Science ®Google Scholar
• Tsai AG, Lieber MR. Mechanisms of chromosomal rearrangement in the human genome. BMC Genomics 2010;11:1–9.
   PubMed Web of Science ®Google Scholar
• Okazaki IM, Hiai H, Kakazu N, et al. Constitutive expression of AID leads to tumorigenesis. J Exp Med 2003;197:1173–1181.
   PubMed Web of Science ®Google Scholar
• Liu M, Duke JL, Richter DJ, et al. Two levels of protection fort the B cell genome during somatic hypermutation. Nature 2008;14: 841–845.
   Web of Science ®Google Scholar
• Feldhan N, Henke N, Melchior K, et al. Activation-induced cytidine deaminase acts as a mutator in BCR-ABL1 transformed acute lymphoblastic leukemia cells. J Exp Med 2007;204:437–439.
   Google Scholar
• Goto A, Hirahashi M, Osada M, et al. Aberrant activation-induced cytidine deaminase expression is associated with mucosal intestinalization in the early stage of gastric cancer. Virchows Arch 2011;458:717–724.
   PubMed Web of Science ®Google Scholar
• Shinmura K, Igarashi H, Goto M, et al. Aberrant expression and mutation-inducing activity of aID in human lung cancer. Ann Surg Oncol 2011;18:2084–2092.
   PubMed Web of Science ®Google Scholar
• Lenz G, Staudt LM. Aggressive lymphomas. N Engl J Med 2010; 362:1417–1429.
   PubMed Web of Science ®Google Scholar
• Marusawa H. Aberrant AID expression and human cancer development. Int J Biochem Cell Biol 2008;40:1399–1402.
   PubMed Web of Science ®Google Scholar
• Liu Z, Wu X, Duan Y, et al. AID expression is correlated with Bcr-Abl expressionin CML-LBC and can be down-regulated by As2O3 and/or imatinib. Leuk Res 2011;35:1355–1359.
   PubMed Web of Science ®Google Scholar
• Marantidou F, Dagklis A, Stalika E, et al. Activation-induced cytidine deaminase splicing patterns in chronic lymphocytic leukemia. Blood Cell Mol Dis 2010;44:262–267.
   PubMed Web of Science ®Google Scholar
• Albesiano E, Messmer BT, Damle RN, et al. Activation-induced cytidine deaminase in chronic lymphocytic leukemia B cells: expression as multiple forms in a dynamic, variably sized fraction of the clone. Blood 2003;102:3333–3339.
   PubMed Web of Science ®Google Scholar
• Heintel D, Kroemer E, Kienle D, et al. High expression of activation-induced cytidine deaminase (AID) mRNA is associated with unmutated IGVH gene status and unfavourable cytogenetic aberrations in patients with chronic lymphocytic leukaemia. Leukemia 2004;18:756–762.
   PubMed Web of Science ®Google Scholar